Secondary amyloidosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{Sahar}} | {{CMG}}; {{AE}} {{Sahar}} | ||
{{SK}}: Reactive amyloidosis | {{SK}}: Reactive amyloidosis, AA amyloidosis | ||
==[[Secondary amyloidosis overview|Overview]]== | ==[[Secondary amyloidosis overview|Overview]]== |
Revision as of 21:46, 7 November 2019
Secondary amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Secondary amyloidosis On the Web |
American Roentgen Ray Society Images of Secondary amyloidosis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Synonyms and keywords:: Reactive amyloidosis, AA amyloidosis
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Secondary amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies